Discontinuing trimethoprim-sulfamethoxazole prophylaxis does not lead to increased risk of rejection in renal transplant patients with stable graft function.
McLaughlin
K
K
Jevnikar
A
A
Lazarovits
A
A
Hollomby
D
D
Muirhead
N
N
D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D000892:Anti-Infective Agents, Urinary / Q000008:administration & dosage* / Q000627:therapeutic use; D006084:Graft Rejection / Q000209:etiology*; D006801:Humans; D007668:Kidney / Q000503:physiopathology*; D016030:Kidney Transplantation; D011184:Postoperative Period; D011315:Preventive Medicine / Q000379:methods; D012307:Risk Factors; D013420:Sulfamethoxazole / Q000009:adverse effects* / Q000627:therapeutic use; D014295:Trimethoprim / Q000008:administration & dosage* / Q000627:therapeutic use
D000890:Anti-Infective Agents; D000892:Anti-Infective Agents, Urinary; D014295:Trimethoprim; D013420:Sulfamethoxazole